Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection

被引:19
|
作者
Zunino, P
Geymonat, L
Allen, AG
Legnani-Fajardo, C
Maskell, DJ
机构
[1] Inst Invest Biol Clemente Estable, Div Microbiol, Montevideo, Uruguay
[2] Univ Cambridge, Dept Clin Vet Med, Ctr Vet Sci, Cambridge CB3 0ES, England
来源
关键词
Proteus mirabilis; ambient temperature fimbria; isogenic mutant; urinary tract infection;
D O I
10.1111/j.1574-695X.2000.tb01516.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proteus mirabilis, a common cause of urinary tract infection, produces a number of different fimbriae, including ambient temperature fimbriae (ATF). These fimbriae are optimally expressed at 23 degrees C and their contribution to urinary tract infection has so far remained unknown. In the present study, a clinical isolate of P. mirabilis and an isogenic allelic replacement mutant unable to express ATF were tested for their ability to cause infection in the ascending urinary tract infection model in mice. The atf mutant colonised the urinary tract as well as the wild-type strain and was also able to outcompete the wild-type strain in a co-challenge experiment. Different non-clinical P. mirabilis isolates showed a reactive AtfA band after Western blot analysis using a polyclonal rabbit AtfA antiserum. These data together suggest that ATF does not play a role in P. mirabilis urinary tract infection. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 50 条
  • [21] Histological findings of ascending urinary tract infections in experimental rats caused by Proteus mirabilis
    Al-Ani, Imad M.
    Al-Murayati, Hayder Y.
    Salman, Mohammad O.
    Ghani, Hameed M.
    BIOMEDICAL RESEARCH-INDIA, 2011, 22 (04): : 425 - 430
  • [22] Comparison Between Phenotypic and Genotypic to Some Virulence Factors of Proteus Mirabilis Isolation from Urinary Tract Infection
    Dawood, Muhammad Majbil
    Mahdi, Zainab Hussein
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2025, 14 (02): : 54 - 58
  • [23] Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis
    Li, X
    Lockatell, CV
    Johnson, DE
    Lane, MC
    Warren, JW
    Mobley, HLT
    INFECTION AND IMMUNITY, 2004, 72 (01) : 66 - 75
  • [24] EVALUATION OF 2 MOUSE MODELS TO MEASURE THE URINARY VIRULENCE OF PROTEUS-MIRABILIS
    PEERBOOMS, PGH
    VERWEYVANVUGHT, AMJJ
    MACLAREN, DM
    ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY, 1982, 48 (02): : 198 - 198
  • [25] MODEL OF AN ASCENDING INFECTION OF URINARY TRACT
    ZIMMERMANN, W
    FRITSCH, H
    ARCHIV FUR HYGIENE UND BAKTERIOLOGIE, 1970, 154 (01): : 58 - +
  • [26] Transcriptome of Proteus mirabilis in the Murine Urinary Tract: Virulence and Nitrogen Assimilation Gene Expression
    Pearson, Melanie M.
    Yep, Alejandra
    Smith, Sara N.
    Mobley, Harry L. T.
    INFECTION AND IMMUNITY, 2011, 79 (07) : 2619 - 2631
  • [27] Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model
    Cadieux, Peter A.
    Chew, Ben H.
    Knudsen, Bodo E.
    DeJong, Kathy
    Rowe, Elaine
    Reid, Gregor
    Denstedt, John D.
    JOURNAL OF UROLOGY, 2006, 175 (06): : 2331 - 2335
  • [28] The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection
    Jacobsen, Sandra M.
    Lane, Mary C.
    Harro, Jean M.
    Shirtliff, Mark E.
    Mobley, Harry L. T.
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2008, 52 (02): : 180 - 193
  • [29] Henoch-Schonlein purpura associated with Proteus mirabilis urinary tract infection
    Rafailidis, Petros I.
    Kapaskelis, Anastasios
    Falagas, Matthew E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (05) : S98 - S99
  • [30] AMMONIA ENCEPHALOPATHY SECONDARY TO URINARY-TRACT INFECTION WITH PROTEUS-MIRABILIS
    SAMTOY, B
    DEBEUKELAER, MM
    CLINICAL RESEARCH, 1978, 26 (06): : A822 - A822